59 results
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
27 May 21
Regulation FD Disclosure
7:01am
and dry eye Clinical Stage PP - 001 eye drops for dry eye and allergic conjunctivitis OBG re - classified from a device to a drug for dry eye and ocular … that had undergone PRK surgery Limited reimbursement for PRK indication With OBG classified as a drug, will pivot development to Persistent Epithelial
DRSLTR
KPRX
Kiora Pharmaceuticals Inc
7 Jul 14
Correspondence regarding draft registration statement
12:00am
Agreements.
The Company classified as “Temporary Equity” the Series A, B, C, and D Preferred Stock in accordance with ASC 480-10-S99-3A, which requires … equity securities to be redeemed, should result in those securities being classified outside of permanent equity. The redemption terms
10-K
xhlmf8r93elp8vdrir09
31 Mar 15
Annual report
12:00am
424B4
dtq55 3udz2nzsb9szw1
13 Feb 15
Prospectus supplement with pricing info
12:00am
8-K
EX-99.1
ukuv1t qa55r
14 Sep 21
Regulation FD Disclosure
4:20pm
DRS/A
w39g67yt4a w4
8 Jul 14
Draft registration statement (amended)
12:00am